Ultrasound contrast agents for echocardiography

Drugs of Today

Volumn 36, Issue 10, 2000, Pages 725-731

  Yasu, T ^a   Schmid Schonbein, G W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUNEX; BR 14; CONTRAST MEDIUM; DIFINITY; ECHOVIST; FS 069; INFOSON; NC 100100; PERFLUOROOCTYL BROMIDE; PERFLUOROPENTANE; SHU 508; SONOGEN; SONOVIST; SONOVUE; UNCLASSIFIED DRUG;

BLOOD VESSEL WALL; ECHOCARDIOGRAPHY; ENDOTHELIUM CELL; HEART MUSCLE PERFUSION; INFLAMMATION; MICROCIRCULATION; RADIATION SCATTERING; REVIEW; ULTRASOUND;

EID: 0033660072     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2000.36.10.599211     Document Type: Review

References (36)

1. Cardiovascular conference. Ultrasound cardiovascular diagnosis
2. Echocardiography of the aortic root
3. Lack of myocardial perfusion immediately after successful thrombolysis: A predictor of poor recovery of left ventricular function in anterior myocardial infarction
4. Two-dimensional contrast echocardiography. I. In vitro development and quantitative analysis of echo contrast agents
5. The importance of defining left ventricular 'area at risk' in vivo during acute myocardial infarction. An experimental evaluation utilizing myocardial contrast 2D-echocardiography
6. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction
7. Effect of static pressure on the disappearance rate of specific echocardiographic contrast agents
8. Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: Identification of myocardial risk area and infarct size in the canine model of ischemia
9. Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptical echocardiograms
10. Improved left ventricular endocardial border delineation and opacification with Optison (FS069), a new echocardiographic contrast agent: Results of a phase III multicenter trial
11. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection
12. Flow dynamics of QW7437, a new dodecafluoropentane ultrasound contrast agent, in the microcirculation: Microvascular mechanisms for the persistent tissue echoenhancement
13. Diagnostic efficacy of SonoVue
14. Preliminary clinical experiments in cardiology with Sonazoid
15. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure
16. Second harmonic ultrasound blood perfusion measurement
17. Transient myocardial cotrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles: Demonstration and potential mechanisms
18. Improved myocardial contrast with second harmonic transient ultrasound response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albumin
19. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion
20. Real-time contrast echo assessment of myocardial perfusion at low emission power: First experimental and clinical results using power pulse inversion imaging
21. Intraoperative assessment of regional myocardial perfusion using quantitative myocardial contrast echocardiography: An experimental evaluation
22. Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes
23. Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles
24. A novel site-targeted ultrasound contrast agent with broad biomedical application
25. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells
26. Acoustically forced oscillation of air bubbles in water: Experimental results
27. Acoustic liability of albumin microspheres
28. Interactions between microbubbles and ultrasound: In vitro and in vivo observations
29. Hemolysis in vivo from exposure to pulsed ultrasound
30. Enhancement of ultrasonically-induced hemolysis by perfluorocarbon-based compared to air-based echo-contrast agents
31. Gas-body-based contrast agent enhances vascular bioeffects of 1.09 MHz ultrasound on mouse intestine
32. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue
33. Diagnostic ultrasound activation of contrast agent gas bodies induces capillary rupture in mice